Understanding consequences of prenatal exposure to psychiatric and analgesic
medications is important because use of these medications among pregnant women is …

This paper reviews the findings from preclinical animal and human clinical research
investigating maternal/fetal, neonatal, and child neurodevelopmental outcomes following …

Clinical studies indicate significant use of prescription, nonprescription and
social/recreational drugs by women during pregnancy; however, limited knowledge exists …

Clinical studies indicate significant use of prescription, nonprescription and
social/recreational drugs by women during pregnancy; however, limited knowledge exists …

This Commentary addresses issues related to exposures to teratogens and makes the case
for increased research into the safety of medication usage during pregnancy for mothers and …

'Can I take this medication now that I am pregnant?', is a question that many health care
professionals have met during consultations with pregnant women. Between 60 and 96% of …

Many drugs with unknown safety profiles are administered to pregnant women, placing their
offspring at risk. I assessed whether behavioral outcomes for children exposed during …

Premarketing studies typically exclude pregnant women and children, although new
regulations have promoted their inclusion in clinical trials. Thus, usage of medicines off …

Over the past two decades, findings on medication use during pregnancy have been
accumulating from observational data. Generally, field studies with prospective recruitment …

Regulatory agencies and a variety of public health entities face the responsibility of
evaluating the safety of maternal use of medications with respect to the developing fetus …